首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver.
【24h】

Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver.

机译:一氧化氮和血管重塑调节分离的灌注肝硬化大鼠肝脏中的肝动脉血管阻力。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND/AIMS: Hepatic arterial resistance is modulated by the hepatic arterioles but the role of NO and vascular remodeling in hepatic arterial resistance in cirrhosis is unknown. METHODS: Cirrhosis was induced by CCl(4) or BDL. Using a bivascular liver perfusion dose-responses curves to methoxamine were obtained from the hepatic artery in absence and presence of L-NMMA. Lumen-diameter, wall thickness and number of smooth muscle nuclei were quantitated in the arteries using image analysis. RESULTS: Hepatic arterial resistance and the response to methoxamine were lower in cirrhosis compared to controls (p< or = 0.04) and lower in BDL compared to CCl(4) (p< or = 0.01). L-NMMA increased the response to methoxamine in CCl(4) (p=0.002) and BDL (p=0.05) but corrected the response only in CCl(4) (p=n.s. vs. control). Wall thickness and the number of smooth muscle nuclei were significantly smaller in cirrhosis compared to controls (p<0.05) and the number of nuclei was also lower in BDL compared to CCl(4) (p=0.005). CONCLUSIONS: NO is the main modulator of hepatic arterial resistance in CCl(4) but not in BDL. Intrahepatic arterial remodeling is present in both cirrhotic models but is greater in BDL. This indicates a larger role of structural changes in the control of hepatic arterial resistance in BDL.
机译:背景/目的:肝小动脉调节肝动脉阻力,但肝硬化中一氧化氮和血管重塑在肝动脉阻力中的作用尚不清楚。方法:CCl(4)或BDL诱发肝硬化。使用双血管肝脏灌注,在不存在和存在L-NMMA的情况下,从肝动脉获得对甲氧明的剂量反应曲线。使用图像分析定量动脉中的管腔直径,壁厚和平滑肌细胞核的数量。结果:与对照组相比,肝硬化患者的肝动脉抵抗力和对甲氧胺的反应要低(p <或= 0.04),与CCl(4)相比,BDL要低(p <或= 0.01)。 L-NMMA增加了CCl(4)(p = 0.002)和BDL(p = 0.05)中对甲氧胺的反应,但仅在CCl(4)中校正了反应(p = n.s。vs.对照)。与对照组相比,肝硬化患者的壁厚和平滑肌细胞核数目显着较小(p <0.05),而与CCl(4)相比,BDL中的细胞核数目也较少(p = 0.005)。结论:NO是CCl(4)而非BDL中肝动脉阻力的主要调节剂。在两种肝硬化模型中均存在肝内动脉重构,但在BDL中更大。这表明在BDL中,结构变化在控制肝动脉阻力中的作用更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号